| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | Strongbridge Biopharma plc | 181,818 | 1,382,000 | 0.20% | ||
| 102 | Carbylan Therapeutics Inc. | 360,000 | 1,303,000 | 0.19% | ||
| 103 | ProQR Therapeutics NV | 150,000 | 1,302,000 | 0.19% | ||
| 104 | LOXO ONCOLOGY INC COM | 45,000 | 1,280,000 | 0.19% | ||
| 105 | MANNKIND CORP | 760,000 | 1,102,000 | 0.16% | Call | |
| 106 | WABTEC CORP | 12,761 | 908,000 | 0.13% | ||
| 107 | ARRAY BIOPHARMA INC | 215,000 | 907,000 | 0.13% | ||
| 108 | DELPHI AUTOMOTIVE PLC | 10,065 | 863,000 | 0.13% | ||
| 109 | ELLOMAY CAPITAL LIMITED | 95,653 | 824,000 | 0.12% | ||
| 110 | WIX COM LTD | 35,460 | 807,000 | 0.12% | ||
| 111 | Former Charter Communication (Del 5/18/2016) | 4,026 | 737,000 | 0.11% | ||
| 112 | Catabasis Pharmaceuticals Inc | 80,742 | 640,000 | 0.09% | ||
| 113 | EZCHIP SEMICONDUCTOR F | 20,447 | 505,000 | 0.07% | ||
| 114 | BIOMARIN PHARMACEUTICAL INC | 3,700 | 388,000 | 0.06% | ||
| 115 | Life Technologies Corp | 36,450 | 358,000 | 0.05% | ||
| 116 | GENVEC INC | 186,500 | 343,000 | 0.05% | ||
| 117 | ISRAEL CHEMICALS LTD SHS | 69,083 | 280,000 | 0.04% | ||
| 118 | A O SMITH | 2,700 | 207,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-16-004256, filed 2016.02.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
